Abhayrab Vaccine

The Abhayrab Vaccine is composed of a Purified Vero Cell Rabies vaccine, which is indicated to prevent and treat rabies before and after exposure to the virus. This vaccine is made by growing the rabies virus in these cells and then purifying it to remove unwanted substances. The purified virus is then inactivated, meaning it can no longer cause disease but can stimulate an immune response. Pre-exposure vaccination is for travellers, those in high-risk occupations, and children living in rabies-prone areas. Post-exposure prophylaxis refers to prompt wound management and vaccination. This vaccine is prepared from the Pitman-Moore strain of the Rabies virus grown in Vero cells. Rabies is an acute, progressive disease caused by the rabies virus, which belongs to the Rhabdoviridae family. It spreads through the saliva of the infected animals after bites or scratches. Though this infection is 100% fatal, it is 100% preventable with timely measures and the correct use of available vaccines, immunoglobulins, or monoclonal antibodies. Individuals with a known hypersensitivity to the Abhayrab Vaccine or its components should not receive it. If an individual is currently experiencing a moderate to severe illness, it may be advisable to delay vaccination until they have recovered. However, a mild illness, such as a common cold, usually does not prevent receiving the vaccine.